Barclays PLC Has $61,000 Position in Conduit Pharmaceuticals Inc. (NASDAQ:CDT)
Barclays PLC lifted its position in Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 892,350 shares of the company’s stock after acquiring an additional 54,523 shares during the quarter. […]
Barclays PLC lifted its position in Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 892,350 shares of the company’s stock after acquiring an additional 54,523 shares during the quarter. […]
